Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Clinical Neuromuscular Disease|March 2, 2026
An Unusual Case of Anti-FGFR3 Antibodies, Sensory Neuropathy, and Adie Pupil in a Patient With Hodgkin Lymphoma in Remission and Review of the LiteratureSydney Peters, Wade Whitt, Alexis A Lizarraga
Seminars in Neurology|December 2, 2016
Getting Rid of Weakness in the ICU: An Updated Approach to the Acute Management of Myasthenia Gravis and Guillain-Barré SyndromeAlexis A Lizarraga, Karlo J Lizarraga, Michael Benatar
Multiple Sclerosis and Related Disorders|September 20, 2021
Peripheral nervous system electrodiagnostic abnormalities in predominantly Hispanic Multiple Sclerosis patientsAlexis A Lizarraga, Kottil W Rammohan, Bianca Weinstock-Guttman, et al.
Neuroepidemiology|November 27, 2018
Medical History and Multiple Sclerosis: A Population-Based Incident Case-Control StudyIbrahim Abdollahpour, Alexis A Lizarraga, Saharnaz Nedjat, et al.
Patient Related Outcome Measures|December 19, 2019
Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and PerspectivesOsman Ozel, Caila B Vaughn, Svetlana P Eckert, et al.
Journal of the Neurological Sciences|January 14, 2026
Impact of corticosteroid use on comorbidities in patients with myasthenia gravis in the US National Veterans Affairs Health NetworkCynthia Z Qi, Yilu Lin, Yuebing Li, et al.
Journal of Clinical Medicine|March 16, 2019
Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot StudyRobert Zivadinov, Niels Bergsland, Ellen Carl, et al.
Multiple Sclerosis and Related Disorders|December 17, 2020
Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosisFranziska E Hildesheim, Deepa P Ramasamy, Niels Bergsland, et al.
Radiology|September 25, 2019
Atrophied Brain T2 Lesion Volume at MRI Is Associated with Disability Progression and Conversion to Secondary Progressive Multiple SclerosisAntonia Valentina Genovese, Jesper Hagemeier, Niels Bergsland, et al.
Vaccines|May 28, 2022
COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough InfectionsDejan Jakimovski, Karen Zakalik, Samreen Awan, et al.
Pageof 1